13 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Trial Group #EBM #Neuro ... #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
New Vertebral, Clinical ... #PrimaryCare #Endo ... #IM #Romosozumab ... #Alendronate #NEJM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
the dermatology clinic ... #Clinical #IM #InfectiousDisease ... RapidProgression #NEJM
Shock Overview
A state of tissue hypoxia due to decreased or dysregulated oxygen delivery or extraction, resulting
, resulting in end-organ ... cell death -> end-organ ... death Common Clinical ... Manifestations • Neuro ... EmmGeezee #Shock #Classification
Shock Overview
A state of tissue hypoxia due to decreased or dysregulated oxygen delivery or extraction, resulting
, resulting in end-organ ... cell death -> end-organ ... death Common Clinical ... Manifestations • Neuro ... EmmGeezee #Shock #Classification
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
#Clinical #Derm ... #IM #Hidradenitis ... HidradenitisSuppurativa #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
are in routine clinical ... been tested in clinical ... Pathophysiology #IM ... Immunosuppression #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
of the primary end ... point of major or clinically ... EBM #Cardiology #IM ... AtrialFibrillation #NEJM